Biocon Pharma Limited - Company Profile

Q: Who are the current directors of Biocon Pharma Limited?

The current directors of Biocon Pharma Limited are Kiran Mazumdar Shaw, Siddharth Mittal, Karaikal Narayanaswamy Murali Krishnan, Soudabi Neduvanchery.

It is a pharma public limited company based in Bangalore, Karnataka, India, established in 2014.

2014 Bangalore, Karnataka, India Active

Last Updated: January 10, 2026

Access Report

About Biocon Pharma Limited

Biocon Pharma Limited, a active public limited company, was established on 31 October 2014 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232KA2014PLC077036. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1,040.15 Cr and a paid-up capital of ₹887.10 Cr.

It upholds a compliant status. Employing 526 professional, Its leadership includes Kiran Mazumdar Shaw (Director), Siddharth Mittal (Whole-Time Director), Karaikal Narayanaswamy Murali Krishnan (Director). Past directors included John Russell Fotheringham Walls, John Mccallum Marshall Shaw, Siddharth Mittal. It holds no open charges and ₹133.00 Cr settled loans. Its latest AGM occurred on 08 August 2025, with the balance sheet filed on 31 March 2025. It is based at 20Km Electronics City, Hosur Road, Bangalore - 560100, Bangalore, Karnataka, 560100.

Company Details

CIN/LLPIN
U24232KA2014PLC077036
Registration Number
077036
Incorporation Date
31 October 2014
Authorized Capital
₹1,040.15 Cr
Paid-Up Capital
₹887.10 Cr
ROC Code
Roc Bangalore
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1,040.15 Cr as on 10-01-2026
Paid Up Capital ₹ 887.10 Cr as on 10-01-2026
Company Age 11 Year, 3 Months
Last Filing with ROC 31 Mar 2025
Satisfied Charges ₹ 133.00 Cr as on 10-01-2026
Revenue Growth **** -1.30% (FY 2023)
Profit Growth **** -57.20% (FY 2023)
Ebitda **** -13.16% (FY 2023)
Net Worth 38.03% (FY 2023)
Total Assets **** 107.65% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Biocon Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Biocon Pharma Limited?

Current Directors

Name	Designation	Appointment Date	Status
Kiran Mazumdar Shaw	Director	31 Oct 2014	Current
Siddharth Mittal	Whole-Time Director	23 Jan 2020	Current
Karaikal Narayanaswamy Murali Krishnan	Director	13 May 2022	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	26 Oct 2017	Past
Pramod Abcsdd	Director	31 Jul 2022	Past
Pramod Abcsdd	Additional Director	23 Jan 2020	Past
Pramod Abcsdd	Company Secretary	26 Oct 2018	Past
Pramod Abcsdd	Cfo(Kmp)	22 Oct 2020	Past
Pramod Abcsdd	Additional Director	22 Jul 2022	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Biocon Pharma.

Biocon Pharma Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.3% decrease. The company also saw a substantial fall in profitability, with a 57.2% decrease in profit. The company's net worth Soared by an impressive increase of 38.03%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-1.30%

*******

Revenue from Operations

*******

-0.82%

*******

Total Assets

*******

107.65%

*******

Profit or Loss

*******

-57.20%

*******

Net Worth

*******

38.03%

*******

EBITDA

*******

-13.16%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Biocon Pharma?

In 2023, Biocon Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹1,330,000,000.00

Charges Breakdown by Lending Institutions

Citi Bank N.A. : 133.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
29 Sep 2016	Citi Bank N.A.	₹133.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Biocon Pharma?

Biocon Pharma has a workforce of 526 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Biocon Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biocon Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Biocon Pharma

Recent Activity within the Organization

Annual General Meeting

The activity Biocon Pharma Limited last Annual general meeting of members was held on 08 Aug 2025 as per latest MCA records. was completed.
08 Aug 2025
Balance Sheet

Progress on Biocon Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was documented.
31 Mar 2025
Director Appointment

The activity Soudabi Neduvanchery was appointed as a Cfo was appointed as a Cfo on 29 Aug 2024 & has been associated with this company since 1 year 5 months . was completed.
29 Aug 2024
Charges

Progress on A charge registered on 29 Sep 2016 via Charge ID 100057801 with Citi Bank N.A. was fully satisfied on 31 May 2022. was documented.
31 May 2022
Director Appointment

The activity Karaikal Narayanaswamy Murali Krishnan was appointed as a Director was appointed as a Director on 13 May 2022 & has been associated with this company since 3 years 8 months . was completed.
13 May 2022
Director Appointment

Progress on Siddharth Mittal was appointed as a Whole-time director was appointed as a Whole-time director on 23 Jan 2020 & has been associated with this company since 6 years 12 days . was documented.
23 Jan 2020

Explore recent activity and updates - View Recent Activity